Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001882764-25-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Dec 23, 2025 |
| Document Date | Dec 22, 2025 |
| Document | View SEC Filing |
Transactions
2
Total Shares
26,000
Total Value
$32,240.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF FINANCIAL OFFICER | Common Stock | โ | Dec 22, 2025 | Exercise/Conversion | 13,000 | $2.48 | $32,240.00 | 36,000 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Stock Option (right to buy) | Derivative | Dec 22, 2025 | Exercise/Conversion | 13,000 | $0.00 | $0.00 | 92,056 | Direct | โ | View Details |